A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors (vol 20, pg 153, 2010)

被引:0
|
作者
Wang, Tiansheng [1 ]
Ledeboer, Mark W. [1 ]
Duffy, John P. [1 ]
Salituro, Francesco G. [1 ]
Pierce, Albert C. [1 ]
Zuccola, Harmon J. [1 ]
Block, Eric [1 ]
Shlyakter, Dina [1 ]
Hogan, James K. [1 ]
Bennani, Youssef L. [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1016/j.bmcl.2010.02.078
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:2684 / 2684
页数:1
相关论文
共 15 条
  • [1] A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors
    Wang, Tiansheng
    Ledeboer, Mark W.
    Duffy, John P.
    Pierce, Albert C.
    Zuccola, Harmon J.
    Block, Eric
    Shlyakter, Dina
    Hogan, James K.
    Bennani, Youssef L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 153 - 156
  • [2] Discovery of polycyclic azaindoles and deazapurines as potent JAK2 inhibitors
    Ledeboer, Mark W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [3] Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold
    Yin, Yuan
    Chen, Cheng-Juan
    Yu, Ru-Nan
    Shu, Lei
    Zhang, Tian-Tai
    Zhang, Da-Yong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (08) : 1562 - 1576
  • [4] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
    Anders Poulsen
    Anthony William
    Stéphanie Blanchard
    Angeline Lee
    Harish Nagaraj
    Haishan Wang
    Eeling Teo
    Evelyn Tan
    Kee Chuan Goh
    Brian Dymock
    Journal of Computer-Aided Molecular Design, 2012, 26 : 437 - 450
  • [5] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
    Poulsen, Anders
    William, Anthony
    Blanchard, Stephanie
    Lee, Angeline
    Nagaraj, Harish
    Wang, Haishan
    Teo, Eeling
    Tan, Evelyn
    Goh, Kee Chuan
    Dymock, Brian
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (04) : 437 - 450
  • [6] Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors
    Jaime-Figueroa, Saul
    De Vicente, Javier
    Hermann, Johannes
    Jahangir, Alam
    Jin, Sue
    Kuglstatter, Andreas
    Lynch, Stephen M.
    Menke, John
    Niu, Linghao
    Patel, Vaishali
    Shao, Ada
    Soth, Michael
    Minh Diem Vu
    Yee, Calvin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2522 - 2526
  • [7] Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase (vol 59, pg 6281, 2016)
    Degorce, Sebastien L.
    Barlaam, Bernard
    Cadogan, Elaine
    Dishington, Allan
    Ducray, Richard
    Glossop, Steven C.
    Hassall, Lorraine A.
    Lach, Franck
    Lau, Alan
    McGuire, Thomas M.
    Nowak, Thorsten
    Ouvry, Gilles
    Pike, Kurt G.
    Thomason, Andrew G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) : 6398 - 6398
  • [8] First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery (vol 52, pg 293, 2009)
    Menichincheri, Maria
    Bargiotti, Alberto
    Berthelsen, Jens
    Bertrand, Jay A.
    Bossi, Roberto
    Ciavolella, Antonella
    Cirla, Alessandra
    Cristiani, Cinzia
    Croci, Valter
    D'Alessio, Roberto
    Fasolini, Marina
    Fiorentini, Francesco
    Forte, Barbara
    Isacchi, Antonella
    Martina, Katia
    Molinari, Antonio
    Montagnoli, Alessia
    Orsini, Paolo
    Orzi, Fabrizio
    Pesenti, Enrico
    Pezzetta, Daniele
    Pillan, Antonio
    Poggesi, Italo
    Roletto, Fulvia
    Scolaro, Alessandra
    Tato, Marco
    Tibolla, Marcellino
    Valsasina, Barbara
    Varasi, Mario
    Volpi, Daniele
    Santocanale, Corrado
    Vanotti, Ermes
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (04) : 1230 - 1230
  • [9] Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms (vol 62, pg 10305, 2019)
    Yang, Tao
    Hu, Mengshi
    Qi, Wenyan
    Yang, Zhuang
    Tang, Minghai
    He, Jun
    Chen, Yong
    Bai, Peng
    Yuan, Xue
    Zhang, Chufeng
    Liu, Kongjun
    Lu, Yulin
    Xiang, Mingli
    Chen, Lijuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) : 1441 - 1442
  • [10] Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
    Zhang, Li
    Zhao, Jingyun
    Zhang, Beichen
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 809 - 816